Sertkaya, A; Wong, H. H.; Jessup, A; Beleche, T (2016). Key cost drivers of pharmaceutical clinical trials in the United States. Clinical Trials. 13 (2): 117—26. doi:10.1177/1740774515625964. PMID26908540.
Holland, John (2013). Fixing a broken drug development process. Journal of Commercial Biotechnology. 19. doi:10.5912/jcb588.
Adams, C. P.; Brantner, V. V. (2006). Estimating the Cost of New Drug Development: Is It Really $802 Million?. Health Affairs. 25 (2): 420—8. doi:10.1377/hlthaff.25.2.420. PMID16522582.
fda.gov
Step 3. Clinical research. US Food and Drug Administration. 14 жовтня 2016. Архів оригіналу за 20 січня 2017. Процитовано 1 лютого 2017.
Sertkaya, A; Wong, H. H.; Jessup, A; Beleche, T (2016). Key cost drivers of pharmaceutical clinical trials in the United States. Clinical Trials. 13 (2): 117—26. doi:10.1177/1740774515625964. PMID26908540.
Adams, C. P.; Brantner, V. V. (2006). Estimating the Cost of New Drug Development: Is It Really $802 Million?. Health Affairs. 25 (2): 420—8. doi:10.1377/hlthaff.25.2.420. PMID16522582.